NDC 0006-5367 – Steglujan
Ertugliflozin Pidolate 5 mg/1; Sitagliptin Phosphate 100 mg/1 · Tablet, Film Coated · Oral
Product NDC0006-5367
Product details
- Brand name
- Steglujan
- Generic name
- Ertugliflozin and sitagliptin
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA209805
- Marketed since
- December 19, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Dipeptidyl Peptidase 4 Inhibitor
Active ingredients
- Ertugliflozin Pidolate 5 mg/1
- Sitagliptin Phosphate 100 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 0006-5367-03 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-5367-03) | Dec 19, 2017 |
| 0006-5367-06 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-5367-06) | Dec 19, 2017 |
| 0006-5367-07 | 500 TABLET, FILM COATED in 1 BOTTLE (0006-5367-07) | Dec 19, 2017 |
| 0006-5367-09 sample | 2 BOTTLE in 1 CARTON (0006-5367-09) / 7 TABLET, FILM COATED in 1 BOTTLE (0006-5367-08) | Dec 19, 2017 |
Other Steglujan products
- 0006-5368 Ertugliflozin Pidolate 15 mg/1; Sitagliptin Phosphate 100 mg/1 · Tablet, Film Coated · Merck Sharp & Dohme LLC